... adjuvants and drug products from preclinical studies through Phase III clinical trials with line of sight to ... nanoparticles, adjuvant systems, live virus, protein conjugates, and/or combinations of these modalities ...

... drug products from preclinical studies through Phase III clinical trials with line of sight to ... experiments to develop stable formulations and robust manufacturing processes for preclinical and clinical ...